Treatment-as-Prevention in AIDS Control: Why Communication Still Matters
DOI:
https://doi.org/10.12970/2309-0529.2013.01.01.1Keywords:
Treatment, prevention, communication.Abstract
Treatment-as-prevention is a term used to describe an HIV prevention method that uses antiretroviral treatment to minimize the chance of HIV transmission, with the idea that treatment can decrease the viral load of those infected to a level where transmission risk is minimal. However, for treatment-as-prevention to be a success, individuals must get tested, know their status, seek care, and adhere to their antiretroviral regimen. Communication plays a role in each of these steps, as communication can be used to create demand for health-seeking behavior and as a means to increase quality and support on the supply side, at the clinic and community level. From the demand side, communication has played a role in convincing people to get tested and obtain their results, in ensuring treatment access, linking those infected to care, and addressing stigmatizing attitudes that may prevent individuals from taking these actions. On the supply side, communication has been shown to mobilize community care and support and increase the quality of patient-provider interaction, which in turn can improve adherence. Finally, communication has played an integral role in structural issues related to treatment-as-prevention, including the assurance of adequate supplies, including HIV testing kits, anti-retrovirals, and condoms.References
[1] Dieffenbach CW, Fauci AS. Universal testing and treatment for prevention of HIV transmission. JAMA. 2009; 301(22): 2380-2. http://dx.doi.org/10.1001/jama.2009.828
[2] Mayer KH, Venkatesh KK. Antiretroviral therapy as HIV prevention: Status and prospects. Am J Public Health 2010; 100(10): 1867-76. http://dx.doi.org/10.2105/AJPH.2009.184796
[3] Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006; 368(9534): 531-6. http://dx.doi.org/10.1016/S0140-6736(06)69162-9
[4] Bingenheimer JB, Geronimus AT. Behavioral mechanisms in HIV epidemiology and prevention: Past, present, and future roles. Studies in Family Planning 2009; 40(3): 187-204. http://dx.doi.org/10.1111/j.1728-4465.2009.00202.x
[5] Coates T, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: How to make them work better. Lancet 2008; 372(9639): 669-84. http://dx.doi.org/10.1016/S0140-6736(08)60886-7
[6] Kippax S, Stephenson N. Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health. Am J Public Health 2012; 102(5): 789-99. http://dx.doi.org/10.2105/AJPH.2011.300594
[7] Padian NS, McCoy SI, Abdool Karim SS, Hasen N, Kim J, Bartos M, et al. HIV prevention transformed: The new prevention research agenda. Lancet 2011; 378(9787): 2269- 78. http://dx.doi.org/10.1016/S0140-6736(11)60877-5
[8] Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: Integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Ann Rev Clin Psychol 2009; 5: 143-67. http://dx.doi.org/10.1146/annurev.clinpsy.032408.153530
[9] Kilmarx PH, Mutasa-Apollo T. Patching a leaky pipe: The cascade of HIV care. Curr Opin HIV AIDS 2013; 8(1): 59-64.
[10] Hull MW, Wu Z, Montaner JS. Optimizing the engagement of care cascade: A critical step to maximize the impact of HV treatment as prevention. Curr Opin HIV AIDS 2012; 7(6): 579-86. http://dx.doi.org/10.1097/COH.0b013e3283590617
[11] Noar SM, Palmgreen P, Chabot M, Dobransky N, Zimmerman RS. A 10-Year Systematic Review of HIV/AIDS Mass Communication Campaigns. J Health Commun 2009; 14(1): 15-42. http://dx.doi.org/10.1080/10810730802592239
[12] Vidanapathirana J, Abramson MJ, Forbes A, Fairley C. Mass media interventions for promoting HIV testing. Cochrane Database of Systematic Rev 2005; 3.
[13] Berendes S, Rimal RN. Addressing the slow uptake of HIV testing in Malawi: The role of stigma, self-efficacy, and knowledge in the Malawi BRIDGE Project. J Assoc Nurses AIDS Care 2011; 22: 215-28. http://dx.doi.org/10.1016/j.jana.2010.08.005
[14] Creel AH, Rimal RN, Mkandawire G, Brown J, Bose K. Effects of a Mass Media Intervention on HIV-Related Stigma: Radio Diaries Program in Malawi. Health Educ Res 2011; 26: 456-65. http://dx.doi.org/10.1093/her/cyr012
[15] Nambiar D, Rimal RN. Duty and destiny: Psychometric properties and correlates of HIV-related stigma among youth NGO workers in Delhi, India. AIDS Care 2012; 24: 1384-91. http://dx.doi.org/10.1080/09540121.2011.648597
[16] Creel AH, Rimal RN. Factors related to HIV testing behavior and interest in testing in Namibia. AIDS Care 2011; 23: 901- 7.
[17] Smith RA. Language of the lost: An explication of stigma communication. Commun Theory 2007; 17(4): 462-85. http://dx.doi.org/10.1111/j.1468-2885.2007.00307.x
[18] Krenn S, Limaye R. The Role of Social and Behavior Change Communication in Combating HIV/AIDS. In: Marlink RG, Teitelman ST, Eds. From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in ResourceLimited Settings. Washington, DC: Elizabeth Glaser Pediatric AIDS Foundation 2009; pp. 135-63.
[19] Heisler M, Bouknight RR, Hayward RA, Smith DM, Kerr EA. The Relative Importance of Physician Communication, Participatory Decision Making, and Patient Understanding in Diabetes Self-Management. J General Internal Med 2002; 17(4): 243-52. http://dx.doi.org/10.1046/j.1525-1497.2002.10905.x
[20] Penn C, Watermeyer J, Evans M. Why don't patients take their drugs? The role of communication, context and culturein patient adherence and the work of the pharmacist in HIV/AIDS. Patient Education Counseling 2011; 83(3): 310-8. http://dx.doi.org/10.1016/j.pec.2011.02.018
[21] Campbell C, Cornish F. Towards a fourth generation of approaches to HIV/AIDS management: creating contexts for effective community mobilisation. AIDS Care 2010; 22(S2): 1569-79. http://dx.doi.org/10.1080/09540121.2010.525812
[22] Zachariah R, Teck R, Buhendwa L, Labana S, Chinji C, Humblet P, et al. How can the community contribute in the fight against HIV/AIDS and tuberculosis? An example from a rural district in Malawi. Trans Royal Soc Trop Med Hygiene 2006; 100(2): 167-75. http://dx.doi.org/10.1016/j.trstmh.2005.07.008
[23] Green EC. Rethinking AIDS Prevention. Westport, CT Praeger 2003.
[24] Wilson D. Partner reduction and the prevention of HIV/AIDS: The most effective strategies come from within communities. Br Med J 2004; 328: 848-9. http://dx.doi.org/10.1136/bmj.328.7444.848
[25] Pemba P. Lack of testing kits slowing AIDS fight. The Nation. 2013 April 2, 2012.
[26] Lynch S, Ford N, van Custem G, Bygrave H, Janssens B, Decroo T, et al. Getting HIV treatment to the most people. Science 2012; 337(6092): 298-300. http://dx.doi.org/10.1126/science.1225702
[27] Pasquet A, Messou E, Gabillard D, Minga A, Depoulosky A, Deuffic-Burban S, et al. Care among HIV infected patients on combination antiretroviral therapy in Cote D'Ivoire. PLoS One 2010; 5(10): e13414. http://dx.doi.org/10.1371/journal.pone.0013414
[28] Schouten EJ, Jahn A, Ben-Smith A, Makombe SD, Harries AD, Aboagye-Nyame F, et al. Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. JAIDS 2011; 14(S1): S4.
[29] Mutchler MG, Wagner G, Cowgill BO, McKay T, Risley B, Bogart LM. Improving HIV/AIDS care through treatment advocacy: going beyond client education to empowerment by facilitating client-provider relationships. AIDS Care 2011; 23(1): 79-90. http://dx.doi.org/10.1080/09540121.2010.496847
[30] Iqbal JM. AIDS and the State: A comparison of Brazil, India and South Africa. South Asian Survey 2009; 16: 119. http://dx.doi.org/10.1177/097152310801600108
[31] WHO. Antiretroviral Treatment as Prevention (TasP) of HIV and TB: 2012 update. Geneva, Switzerland: World Health Organization 2012.
[32] Flynn M. Origins and Limitations of State-based Adovcacy: Brazil's AIDS Treatment Program and Global Power Dynamics. Politics Society 2013; 41(3): 3-28. http://dx.doi.org/10.1177/0032329212473086
[33] Hammer SM. Antiretroviral treatment as prevention N Engl J Med 2011; 365: 561-562.
